University of Manchester: Biomarker Test Could Significantly Reduce Antibiotic Use in Sepsis, Finds Trial
December 11, 2024
December 11, 2024
MANCHESTER, England, Dec. 11 (TNSres) -- The University of Manchester issued the following news release:
A major UK patient trial of a new biomarker testing protocol for sepsis, led by University of Manchester researchers, has shown it is possible to safely stop antibiotic treatment earlier than current care.
The duration reduction of around 10% could provide significant cost savings to health systems, limit unwanted drug side-effects, reduce overtreatment and reduce th . . .
A major UK patient trial of a new biomarker testing protocol for sepsis, led by University of Manchester researchers, has shown it is possible to safely stop antibiotic treatment earlier than current care.
The duration reduction of around 10% could provide significant cost savings to health systems, limit unwanted drug side-effects, reduce overtreatment and reduce th . . .